“…Accumulating evidence indicates that classically activated and alternatively activated MMΦ within the lesion area can individually contribute to tissue damage or repair in the brain under conditions of spinal cord injury (Kigerl et al, 2009; Kroner et al, 2014), traumatic brain injury (Kumar et al, 2013; Wang et al, 2013), ischemic stroke (Hu et al, 2012), multiple sclerosis (Mikita et al, 2011), and Parkinson’s disease (Pisanu et al, 2014). To date, no study has comprehensively characterized MMΦ dynamics or delineated the functional significance of MMΦ phenotype on hematoma resolution in vivo (Wan et al, 2016; Zhang et al, 2016; Zhao et al, 2015a). …”